Schattenberg, Jörn M.
Balp, Maria-Magdalena
Reinhart, Brenda
Tietz, Andreas
Regnier, Stephane A.
Capkun, Gorana
Ye, Qin
Loeffler, Jürgen
Pedrosa, Marcos C.
Docherty, Matt
Funding for this research was provided by:
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 16 June 2022
Accepted: 29 March 2023
First Online: 5 April 2023
Competing interests
: JMS reports consulting fees from Boehringer Ingelheim, Genfit, Gilead Sciences, Intercept Pharmaceuticals, Madrigal, Novartis, Pfizer, Roche, and Siemens Healthineers. MMB, AT, GC, and JL are employees of Novartis Pharma AG. SAR and MCP were employees of Novartis Pharma AG at the time of study execution. BR, QY, and MD are employees of ZS Associates.